I'm thrilled to continue the mission to bring forward important new cancer therapies as part of the Life Sciences team @GVteam. Stay tuned!
John Carroll@JohnCendpts
Exclusive: GV’s David Schenkein turns to a familiar face at Novartis for his latest recruit as entrepreneur-in-residence endpts.com/exclusive-gvs-…
English